| Literature DB >> 20534130 |
Jesper Ryge1, Ole Winther, Jacob Wienecke, Albin Sandelin, Ann-Charlotte Westerdahl, Hans Hultborn, Ole Kiehn.
Abstract
BACKGROUND: Spinal cord injury leads to neurological dysfunctions affecting the motor, sensory as well as the autonomic systems. Increased excitability of motor neurons has been implicated in injury-induced spasticity, where the reappearance of self-sustained plateau potentials in the absence of modulatory inputs from the brain correlates with the development of spasticity.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20534130 PMCID: PMC2900267 DOI: 10.1186/1471-2164-11-365
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Consensus clustering define distinct time profiles of gene expression. Consensus clusters of the 3,708 most differentially expressed genes. A. Heatmaps of each consensus cluster illustrating the expression pattern of the genes contained in each cluster. The gene wise expression has been normalized according to eq. 1 resulting in expression between -1 and +1. Color Code: Red signifies up-regulation and green down-regulation compared to the gene-wise average (see color bar). The alternating colored bars below each heatmap illustrate the microarrays of each time point 0, 2, 7, 21 and 60 days post injury. B. The average expression time profile of each consensus cluster, plus/minus one standard deviation. C. Optimal leaf ordered dendrogram showing the Ward distance between each consensus cluster. D. Contour map of the (leaf ordered) co-occurrence matrix. The consensus clusters are indicated along the diagonal with numbers. This figure illustrates the gene overlap between clusters for the consecutive cluster runs with randomized initial settings.
Over-represented ontologies of each gene cluster
| Ontology Term | Class | Count | Total | Terms |
|---|---|---|---|---|
| Cell-cell adhesion | BP | 18 | 34 | 9 |
| Ensheathment of neurons | BP | 7 | 7 | 4 |
| Zinc finger, C2H2-type | INTERPRO | 11 | 11 | 4 |
| L-amino acid transmembrane transporter activity | MF | 7 | 9 | 8 |
| Solute:cation symporter activity | MF | 6 | 9 | 6 |
| Nucleosome assembly | BP | 6 | 14 | 10 |
| Ribonucleoprotein complex | CC | 31 | 54 | 16 |
| Translation | BP | 23 | 54 | 16 |
| Intracellular part | CC | 143 | 162 | 8 |
| RNA splicing | BP | 9 | 14 | 9 |
| Ribonucleoprotein complex biogenesis | BP | 10 | 14 | 4 |
| Macromolecule metabolic process | BP | 95 | 110 | 4 |
| Mitochondrial ribosome | CC | 4 | 4 | 4 |
| Regulation of apoptosis | BP | 16 | 37 | 12 |
| Cell-cell adhesion | BP | 22 | 44 | 11 |
| Metal ion binding | MF | 97 | 98 | 4 |
| Cellular metabolic process | BP | 198 | 217 | 4 |
| Regulation of biosynthetic process | BP | 12 | 19 | 4 |
| Macromolecule biosynthetic process | BP | 37 | 52 | 4 |
| Ribosome | KEGG | 12 | 38 | 9 |
| Cell part | CC | 294 | 294 | 8 |
| Peptidase M, neutral zinc metallopeptidase, zinc binding | INTERPRO | 5 | 8 | 4 |
| Zinc finger, C2H2-type | INTERPRO | 10 | 10 | 4 |
| Ligase activity, forming carbon-nitrogen bonds | MF | 13 | 19 | 6 |
| Cytosolic large ribosomal subunit | CC | 6 | 11 | 5 |
| RNA metabolic process | BP | 43 | 85 | 14 |
| Cellular metabolic process | BP | 108 | 117 | 4 |
| Monooxygenase activity | MF | 5 | 9 | 7 |
| Inflammatory response | BP | 21 | 50 | 4 |
| Adaptive immune response | BP | 8 | 12 | 16 |
| Pancreatitis-associated protein | INTERPRO | 4 | 7 | 6 |
| Chemokine activity | MF | 5 | 10 | 10 |
| Ras | INTERPRO | 10 | 20 | 8 |
| GTP binding | MF | 19 | 19 | 8 |
| Biopolymer modification | BP | 5 | 6 | 5 |
| Immunoglobulin subtype | INTERPRO | 9 | 12 | 8 |
| Cytokine production | BP | 6 | 10 | 8 |
| Glycosyltransferase | PIR | 8 | 10 | 12 |
| Ribonucleotide binding | MF | 32 | 37 | 8 |
| Contractile fiber part | CC | 4 | 4 | 4 |
| Ras | INTERPRO | 6 | 10 | 8 |
| Tyrosine-specific protein kinase | PIR | 4 | 10 | 9 |
| Kinase activity | MF | 18 | 25 | 19 |
| Hydrolase activity, hydrolysing O-glycosyl compounds | MF | 5 | 9 | 4 |
| Biopolymer modification | BP | 28 | 60 | 6 |
| Positive regulation of transcription from RNA polymerase II | BP | 7 | 45 | 25 |
| EGF-like | INTERPRO | 7 | 7 | 10 |
| Anatomical structure development | BP | 43 | 66 | 6 |
| Membrane part | CC | 75 | 75 | 4 |
| Transporter activity | MF | 32 | 35 | 8 |
| Transcription coactivator activity | MF | 8 | 14 | 4 |
| Intracellular transport | BP | 23 | 26 | 8 |
| Integral to endoplasmic reticulum membrane | CC | 5 | 8 | 7 |
| Coated vesicle | CC | 9 | 11 | 6 |
| Protein amino acid phosphorylation | BP | 28 | 64 | 14 |
| Plasma membrane part | CC | 31 | 53 | 4 |
| Protein kinase, core | INTERPRO | 16 | 22 | 6 |
| Immunoglobulin-like | INTERPRO | 13 | 13 | 5 |
| Neurotransmitter transporter activity | MF | 5 | 12 | 14 |
| System development | BP | 52 | 72 | 5 |
| Gated channel activity | MF | 13 | 28 | 28 |
| Neurological system process | BP | 29 | 30 | 4 |
| ATP binding | MF | 37 | 45 | 8 |
| Cation transmembrane transporter activity | MF | 19 | 39 | 8 |
| Negative regulation of fibroblast proliferation | BP | 4 | 10 | 11 |
| Axogenesis | BP | 9 | 18 | 14 |
| Regulation of neurotransmitter levels | BP | 9 | 14 | 6 |
| Membrane part | CC | 98 | 111 | 4 |
| Glycolysis | BP | 13 | 37 | 25 |
| Transporter activity | MF | 40 | 40 | 6 |
| Purine ribonucleotide binding | MF | 45 | 48 | 9 |
| Positive regulation of nucleobase, nucleoside, nucleotide | BP | 13 | 15 | 5 |
| Synaptic transmission | BP | 17 | 31 | 5 |
| Phosphorylation activity | BP | 24 | 49 | 25 |
| Active transmembrane transporter activity | MF | 16 | 31 | 47 |
| Phosphorylation activity | MF | 22 | 35 | 6 |
| Neuron differentation | BP | 14 | 20 | 14 |
| Cell development | BP | 34 | 37 | 11 |
| Monovalent inorganic cation homeostasis | BP | 5 | 12 | 10 |
| Amine transport | BP | 7 | 12 | 4 |
| Ion exchanger activity | BP | 10 | 10 | 11 |
| Calycin | INTERPRO | 10 | 10 | 6 |
| Synaptic transmission | BP | 18 | 27 | 5 |
| DNA repair | BP | 10 | 21 | 4 |
| Neuron projection development | BP | 11 | 24 | 17 |
| Developmental process | BP | 61 | 61 | 4 |
| Glycealdehyde-3-phosphate dehydrogenase () | MF | 5 | 20 | 21 |
| Activation of adenylatecyclase activity by G-protein signaling pathway | BP | 4 | 9 | 7 |
| Mitochondrial ATP synthesis coupled electron transport | BP | 10 | 19 | 9 |
| Mitochondrial part | CC | 31 | 44 | 8 |
| Oxidative phosphorylation | KEGG | 21 | 28 | 5 |
| Primary active transmembrane transporter activity | MF | 15 | 26 | 13 |
| Tricarboxylic acid cycle | BP | 6 | 9 | 11 |
| Ion transmembrane transporter activity | MF | 23 | 37 | 10 |
| ATPase activity, coupled to transmembrane movement of substances | MF | 12 | 23 | 39 |
| Alkali metal ion binding (K+) | MF | 8 | 14 | 23 |
| Anion channel activity | MF | 5 | 14 | 23 |
Class Ontology: MF = molecular function, BP = biological process, CC = cellular component, PIR = protein information resource. Count: Number of genes in ontology. Total: Number of genes in ontology cluster. Terms: number of ontology terms in ontology cluster.
Differentially expressed genes relating to motor neuron excitability
| Probe IDs | Gene ID | Protein ID | Cluster |
|---|---|---|---|
| 1371039_at | CAB4 | 4 | |
| 1368398_at | Cav3.2 | 8 | |
| 1371175_a_at | Cav2.2 | 9 | |
| 1369706_at | Cacng1 | 10 | |
| 1386939_a_at | Cav2.1 | 11 | |
| 1379307_at | SAP1 | 1 | |
| 1369662_at | Nav1.2 | 3 | |
| 1368539_at | Nav1.7 | 5 | |
| 1383435_at | SCN3B | 5 | |
| 1370850_at | SCN3B | 5 | |
| 1387010_s_at | SCN1B | 8 | |
| 1368351_at | Nav1.8 | 8 | |
| 1388035_a_at | Nav1.5 | 9 | |
| 1370439_a_at | Kv3.2 | 1 | |
| 1369043_at | Kv1.4 | 2 | |
| 1386770_x_at | KCNE2 | 2 | |
| 1385226_at | KCD11 | 3 | |
| 1387264_at | TASK-1 | 5 | |
| 1370958_at | Kv3.3 | 8 | |
| 1389120_at | Kv3.3 | 9 | |
| 1369847_at | KCAB1 | 9 | |
| 1369280_at | TASK-3 | 9 | |
| 1370595_a_at | KCIP4 | 9 | |
| 1370558_a_at | Kv3.2 | 9 | |
| 1387477_at | THIK-2 | 10 | |
| 1370545_at | Kv1.1 | 11 | |
| 1368343_at | Kv11.2 | 11 | |
| 1368751_at | Kv9.3 | 12 | |
| 1374582_at | KCD9 | 12 | |
| 1368524_at | Kv3.1 | 12 | |
| 1370076_at | Kir5.1 | 12 | |
| 1367772_at | Clns1a | ICLN | 1 |
| 1367893_a_at | Clcc1 | CLCC1 | 2 |
| 1378658_at | Clca6 | CLCA6 | 9 |
| 1392453_at | Clcn3 | CLCN3 | 10 |
| 1380547_at | Clcn3 | CLCN3 | 10 |
| 1379932_at | Clcn4-2 | CLCN4-2 | 12 |
| 1369993_at | KCC2G | 9 | |
| 1398251_a_at | KCC2B | 9 | |
| 1369937_at | CALM | 11 | |
| 1370853_at | CK2N1 | 11 | |
| 1368101_at | CALM | 12 | |
| 1369886_a_at | CaBP1 | 11 | |
| 1368005_at | ITPR3 | 7 | |
| 1387286_at | mGluR1 | 1 | |
| 1398889_at | GL1AD | 1 | |
| 1396696_at | GluR4 | 3 | |
| 1369036_at | GRIK2 | 4 | |
| 1368572_a_at | NR1 | 8 | |
| 1368759_at | CCG2/TARP | 10 | |
| 1372724_at | NMDARA1 | 10 | |
| 1369128_at | GRIK5 | 10 | |
| 1387559_at | NMDA3B | 11 | |
| 1368170_at | GAT1 | 1 | |
| 1380170_at | GBRL2 | 1 | |
| 1380828_at | GBRA1 | 1 | |
| 1391653_at | GBRG2 | 1 | |
| 1370702_at | GBRR3 | 9 | |
| 1370804_at | GBRAP | 10 | |
| 1378842_at | GBRL1 | 11 | |
| 1387383_at | GBRR2 | 12 | |
| 1369904_at | GBRB1 | 12 | |
| 1367783_at | GBRL2 | 12 | |
| 1387696_a_at | GLRA2 | 2 | |
| 1370607_a_at | NRG1 | 9 | |
| 1369845_at | ACHA6 | 9 | |
| 1369252_a_at | ACHA4 | 9 | |
| 1368615_a_at | VAChT | 10 | |
| 1368734_at | ACHD | 10 | |
| 1369456_at | 5HT2BR | 5 | |
| 1369119_a_at | 5HT7BR | 11 | |
| 1368534_at | ADA1D | 8 | |
| 1388757_at | ARBK1 | 10 | |
| 1369797_at | ADA1A | 11 | |
| 1368602_at | DAT | 6 | |
| 1368601_at | DAT | 9 | |
| 1387520_at | DRD4 | 9 | |
| 1369856_at | DRD5 | 11 | |
| 1376345_at | ( | 12 | |
| 1369677_at Cnr1 | CB1 | 1 | |
| 1367853_at | NKCC1 | 1 | |
| 1368082_at | AE2 | 10 | |
| 1368772_at | AE3 | 10 | |
Differentially expressed genes of transcription factors (TF) and over-representation (over-rep) of TF binding sequences within each gene cluster
| DEG of TF | ||||
|---|---|---|---|---|
| Clusters | Gene ID | Protein ID | TF over-rep | Motifs |
| T2EB | E2F1 | E2F1_Q3_01 | ||
| NFYC | FOXO1 | E2F1_Q2_01 | ||
| OLIG1 | E2F1_Q6_01 | |||
| PBX3 | FOXO1_01 | |||
| TFB2M | FOXO1_02 | |||
| E2F5 | FOXO1 | FOXO1_01 | ||
| MO4L1 | FOXO1_02 | |||
| AATF | FOXO1 | FOXO1_01 | ||
| BTF3 | FOXO1_02 | |||
| KLF10 | ||||
| ARID1B | E2F1 | E2F1_Q3_01 | ||
| GT2D1 | FOXO1 | FOXO1_01 | ||
| IRF9 | FOXO1_02 | |||
| ATF4 | ATF4_Q2 | |||
| YBX1 | ||||
| ATF4 | ATF4_Q2 | |||
| E2F1 | E2F1_Q3 | |||
| MYC | MYC_Q2 | |||
| SP1 | SP1_01 | |||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| ATF3 | ATF3_Q6 | |||
| ATF4 | ATF4_Q2 | |||
| TF3C1 | E2F1 | E2F1_Q3 | ||
| MYC | E2F1_Q3_01 | |||
| SP1 | E2F1_Q4 | |||
| E2F1_Q4_01 | ||||
| E2F1_Q6 | ||||
| E2F1_Q6_01 | ||||
| MYC_Q2 | ||||
| SP1_01 | ||||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| ATF3 | ATF3_Q6 | |||
| ATF4 | ATF4_Q2 | |||
| E2F1 | E2F1_Q3 | |||
| MYC | E2F1_Q3_01 | |||
| SP1 | E2F1_Q6 | |||
| MYC_Q2 | ||||
| SP1_01 | ||||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| ATF3 | ATF3_Q6 | |||
| E2F1 | E2F1_Q3 | |||
| SP1 | E2F1_Q6 | |||
| SP1_01 | ||||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| ATF4 | ATF4_Q2 | |||
| E2F1 | E2F1_Q3 | |||
| MYC | E2F1_Q3_01 | |||
| SP1 | E2F1_Q4 | |||
| E2F1_Q4_01 | ||||
| E2F1_Q6 | ||||
| E2F1_Q6_01 | ||||
| MYC_Q2 | ||||
| SP1_01 | ||||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| AFT3 | ATF3_Q6 | |||
| E2F1 | E2F1_Q3 | |||
| MYC | MYC_Q2 | |||
| SP1 | SP1_01 | |||
| SP1_Q2_01 | ||||
| SP1_Q4_01 | ||||
| SP1_Q6 | ||||
| SP1_Q6_01 | ||||
| NFIA | AFT3 | ATF3_Q6 | ||
| NKX6-2 | E2F1 | E2F1_Q3_01 | ||
| FOXO1 | E2F1_Q4_01 | |||
| E2F1_Q6 | ||||
| E2F1_Q6_01 | ||||
| FOXO1_01 | ||||
DEG TF: Differentially expressed genes (DEG) of transcription factors (TF). Genes of TF with annotated TRANSFAC motifs are highlighted in boldface. TF over-rep: TFs with over-represented binding sites in the set of genes belonging to the specified gene cluster. Motifs: Individual TRANSFAC motifs with Z scores above 3 based on ASAP conducted on the set of genes belonging to the specified gene cluster.
Figure 2Overlap between transcription factors and their binding motifs. Transcription factor overlap between the 119 transcription factors included on the RAT230 2 chip and their binding motifs contained in TRANSFAC or JASPAR. A. Circle to the left represents the set of transcription factors included on the RAT230 2 chip, in total 119 of which 34 are differentially expressed. TRANFAC contains DNA binding motifs of 541 distinct transcription factors, 29 of which are on the array. Of these 6 are differentially expressed (green) and 23 are non-differentially expressed (red). Thus 28 (grey) differentially expressed transcription factors do not have binding motifs in TRANFAC, which on the other hand contains binding motifs of 512 transcription factors not contained on the microarray (yellow). B. Overlap between the transcription factors included on the RAT230 2 chip and their biding motifs contained in JASPAR. Same color code as in A.
Figure 3Motif over-representation of differentially expressed transcription factors. Over-representation statistics for each cluster profile of the 16 binding motifs contained in TRANSFAC representing the 6 differentially expressed transcription factors: ATF3, ATF4, E2F1, FOXO1, MYC, SP1. A. Heatmap of Z scores organized by two-way hierarchical clustering according to the Z score pattern across binding motifs and cluster profiles. For plotting purposes each Z score vector was normalized to unit variance. Over-represented genes are highlighted in red while under-represented transcription factors are shown in green (see color bar). It is clear that consensus clusters 1-4 and 6-11 group together, sharing common over- as well as under-represented transcription factor motifs. It is also striking that motifs over-represented in these groups typically will be under-represented in the other and vice versa. Consensus clusters 5 and 12 have different patterns of binding motifs Z scores. B. Principal components of the Z score vectors of each consensus cluster (columns of A) validate the pattern observed in A: cluster profiles 1-4 and 6-11 are closely grouped while cluster profiles 5 and 12 are separated from these.